EnGeneIC’s second generation COVID-19 vaccine protects against all variants
SYDNEY, Australia, June 28, 2022 (GLOBE NEWSWIRE) -- The world’s first COVID-19 vaccine to offer immunity against all variants is...
News
Theralase Expands Intellectual Property Portfolio
TORONTO, June 28, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical...
Decibel Therapeutics Reports Positive Data from Interim Analysis of Ongoing Phase 1b Clinical Trial of DB-020 in Patients Receiving Cisplatin Chemotherapy
- 87% of patients who experienced ototoxicity in their placebo-treated ear were protected from ototoxicity in their DB-020-treated ear –...
Revolution Medicines Advances First RAS(ON) Inhibitor into Clinic, Dosing First Patient in Phase 1/1b Trial of RMC-6236
First-in-class, oral, RAS(ON) Inhibitor being evaluated initially in patients with cancers driven by KRASG12 mutations Sushil Patel, Ph.D., industry veteran...
Axsome Therapeutics Hosts Sunosi® Investor Update Virtual Event Today with Key Opinion Leaders
NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel...
ProQR to Participate in the LifeSci 2nd Annual Genetic Medicines Symposium
LEIDEN, Netherlands & CAMBRIDGE, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company...
Asensus Surgical to Showcase the Senhance Surgical System and Performance-Guided Surgery in Upcoming Society of Robotic and Digital Surgery Conference
RESEARCH TRIANGLE PARK, N.C., June 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company...
Pyxis Oncology to Present at H.C. Wainwright Preclinical Cancer Drug Discovery Conference
CAMBRIDGE, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), an oncology company focused on developing next-generation...
Roivant Sciences Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2022 and Provides Business Update
Potential blockbuster VTAMA® (tapinarof) approved by FDA for the treatment of plaque psoriasis at end of May 2022 is the...
West Island Makes First Delivery to SQDC
Dorval, Quebec--(Newsfile Corp. - June 28, 2022) - West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTC Pink: WIBFF) ("West...
Red Light Holland Update Plans to Enter Oregon Legal Psilocybin Service Market to Promote Diversity and Equity in Alignment with Measure 109 Regulations
● Red Light Holland launches: 'Red Light. Set. Go!' program to work with exceptional local Oregonians from diverse backgrounds who...
Siemens Healthineers and The Ohio State University Wexner Medical Center Announce Strategic Partnership Focused on Personalized Medicine and Increased Access to High Quality Healthcare
- Ohio State Wexner Medical Center and Siemens Healthineers have committed to a new strategic relationship to bring the most...
Stryker Launches “Free Your Feet” Campaign to Raise Awareness About New Bunion Treatments
National Campaign to Feature Eye-Catching Experience in Four Major Metropolitan Cities Beginning June 27 KALAMAZOO, Mich.--(BUSINESS WIRE)--#rebuildinglivestogether--Stryker (NYSE:SYK), one of...
Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus
Brepocitinib is a potential first-in-class dual, selective inhibitor of TYK2 and JAK1; in all five placebo-controlled studies completed to date,...
Pharnext: Findings on Symptoms Burden of Charcot-Marie-Tooth Disease Type 1A From the ‘Real-World’ Digital Lifestyle Study, CMT&Me, to be Presented at the ICNMD 2022
PARIS, FRANCE / ACCESSWIRE / June 28, 2022 / Pharnext SA (FR0011191287 - ALPHA) (the "Company"), an advanced late-clinical stage...
Verisante Technology Inc. Announces Share Issuance
VANCOUVER, BC / ACCESSWIRE / June 27, 2022 / Verisante Technology Inc. (NEX:VER.H) (the "Company") announces that further to the...
Cybersecurity, Privacy, Data and Regulatory Compliance Rank as Top IT Audit Risks
New study by Protiviti and ISACA underscores security risks looming large in today's dynamic threat landscape MENLO PARK, Calif., June...
CLEARLAKE CAPITAL TO SELL BRIGHTLY SOFTWARE TO SIEMENS
Under Clearlake's ownership, Brightly transformed into a leading cloud-based asset management software platform with a broad suite of products solving...
Prime Minister announces additional sanctions in support of Ukraine
ELMAU, Germany, June 27, 2022 /CNW/ - Canada is committed to standing in unity to support the government and people of...
Google Cloud Platform achieves Cloud Assurance Certification demonstrating commitment to life sciences companies to meet their global compliance requirements
Cloud Assurance Certified technologies must undergo the rigorous compliance, security, and data integrity assessment by USDM Life Sciences and demonstrate...
